Antimicrobial susceptibility patterns for pathogens isolated from patients in Latin American medical centers with a diagnosis of pneumonia: Analysis of results from the SENTRY Antimicrobial Surveillance Program (1997)

Diagnostic Microbiology and Infectious Disease

Volumn 32, Issue 4, 1998, Pages 289-301

  Sader, Helio S ^a   Jones, Ronald N ^b   Gales, Ana C ^b   Winokur, P ^b   Kugler, Kari C ^b   Pfaller, Michael A ^b   Doern, Gary V ^b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; AZTREONAM; CARBAPENEM; CEFAZOLIN; CEFEPIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; GATIFLOXACIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; OFLOXACIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN; SPARFLOXACIN; STREPTOGRAMIN; TEICOPLANIN; TETRACYCLINE DERIVATIVE; TIMENTIN; TOBRAMYCIN; TROVAFLOXACIN; VANCOMYCIN;

ACINETOBACTER; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; ENTEROBACTER; HUMAN; KLEBSIELLA; LOWER RESPIRATORY TRACT INFECTION; MINIMUM INHIBITORY CONCENTRATION; PNEUMONIA; PREVALENCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BACTERIA; HUMANS; LATIN AMERICA; MICROBIAL SENSITIVITY TESTS; PNEUMONIA;

EID: 0032423825     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(98)00124-2     Document Type: Article

References (28)

1. American Thoracic Society (1996) Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventative strategies. Am J Respir Crit Care Med 153:1711-1725.
2. Baraibar J, Correa H, Mariscal D, Gallego M, Valles J, Rello J (1997) Risk factors for infection by Acinetobacter baumannii in intubated patients with nosocomial pneumonia. Chest 112:1050-54.
3. Bush K, Jacoby GA, Medeiros AA (1995) A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 39:1211-1233.
4. Bartlett JG. (1997) Pneumonia In: Respiratory Tract Infections. Eds, Pine Jr JW and Mullen ML. Baltimore: Williams & Wilkins, pp. 1-117.
5. Cartwright SJ, Waley SG (1984) Purification of β-lactamases by affinity chromatography on phenyllboronic acid-agarose. Biochemical J. 221:505-512.
6. Center for Diseases Control and Prevention (1997) Guidelines for prevention of nosocomial pneumonia. MMWR 46:6-7.
7. Cormican MG, Marshall SA, Jones RN (1996) Detection of Extended-spectrum β-lactamase (ESBL)-producing strains by Etest ESBL screen. J Clin Microbiol 34:1880-1884.
8. Doern GV, Jones RN, Hugh Gerlach E, Washington JA, Biedenbach DJ, Brueggemann A, Erwin ME, Knapp C, Raymond J (1995) Multicenter clinical laboratory evaluation of a β-lactamase disk assay employing a novel chromogenic cephalosporin, S1. J Clin Microbiol 33:1665-1667.
9. Fagon JY, Chastre J, Domart Y (1989) Nosocomial pneumonia in patients receiving continuous mechanical ventilation: Prospective analysis of 52 episodes with use of a protected specimen brush and quantitative culture techniques. Am Rev Respir Dis 139:877-84.
10. Forster DH, Daschner FD (1998) Acinetobacter species as nosocomial pathogens. Eur J Clin Microbiol Infect Dis 17:73-77.
11. Jones RN (1996) Impact of changing pathogens and antimicrobial susceptibility patterns in the treatment of serious infections in hospitalized patients. Am J Med 100(suppl 6A):3S-12S.
12. Jones RN (1997) Can antimicrobial activity be sustained? An appraisal of orally administered drugs used for respiratory tract infections. Diagn Microbiol Infect Dis 27:21-28.
13. Lynch JP, Niederman MS (1997) Controversies in respiratory infections. Semin Respir Infect 12:269-270.
14. Mandell LA, Campbell GD Jr (1998) Nosocomial pneumonia guidelines. An international perspective. Chest 113: 188S-193S.
15. National Committee for Clinical Laboratory Standards (1997) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th ed.: Approved Standard, M7-A4. Wayne, PA.
16. National Committee for Clinical Laboratory Standard (1998) Performance standards for antimicrobial susceptibility testing; eight informational supplement M100-S8. Wayne, PA.
17. Pfaller MA, Jones RN, Doern GV, Kugler K, and the Sentry Participants Group (1998) Bacterial pathogens isolated from patients with blood stream infection: frequencies of occurrence and antimicrobial susceptibility patterns from SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). Antimicrob Agents Chemother 42:1762-1770.
18. Pfaller MA, Wendt C, Mollis RJ (1996) Comparative evaluation of an automated ribotyping system versus pulsed-field gel electrophoresis for epidemiological typing of clinical isolates of Escherichia coli and Pseudomonas aeruginosa from patients with recurrent gram-negative bacteremia. Diagn Microbiol Infect Dis 25:1-8.
19. Rello J, Ricart M, Ausina V, Net A, Prats G (1990) Pneumonia due to Haemophilus influenzae among mechanically ventilated patients: Incidence, outcome, and risks factors. Am Rev Respir Dis 142:1320-1324.
20. Rello J, Rue M, Jubert P, Muses G, Sonora R, Valles J, Niederman MS (1997) Survival in patients with nosocomial pneumonia: Impact of the severity of illness and the etiologic agent. Crit Care Med 25:1862-1867.
21. Sader HS, Pfaller MA, Jones RN (1994) Prevalence of important pathogens and the antimicrobial activity of parenteral drugs at numerous medical centers in the United States. II. Study of the intra-and inter-laboratory dissemination of extended spectrum β-lactamase producing Enterobacteriaceae. Diagn Microbiol Infect Dis 20:203-208.
22. Schleupner CJ, Cobb DK (1992) A study of the etiologies and treatment of nosocomial pneumonia in a community-based teaching hospital. Infect Control Hosp Epidemiol 13:515-525.
23. Spencer RC (1996) Predominant pathogens found in the European prevalence of infection in intensive care study. Eur J Clin Microbiol Infect Dis 15:281-284.
24. Talon D, Mulin B, Rouget C, Bailly P, Thouverez M, Viel JF (1998) Risks and routes for ventilator-associated pneumonia with Pseudomonas aeruginosa. Am J Respir Crit Care Med 157:978-984.
25. Torres A, Aznar R, Gatell JM, Jimenez P, Gonzales J (1990) Incidence, risk and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am Rev Resp Dis 142:523-528.
26. Troillet N, Samore MH, Carmeli Y (1997) Imipenem-resistant Pseudomonas aeruginosa: Risk factors and antibiotic susceptibility patterns. Clin Infect Dis 25:1094-1098.
27. Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J (1995) The prevalence of nosocomial infection in intensive care units in Europe. Results of the European prevalence of infection in intensive care (EPIC) study. EPIC International Advisory Committee. JAMA 274:639-644.
28. Yangan MB (1997) Hospital-acquired pneumonia and its management. Crit Care Nurs 20:36-43.